AstraZeneca is working in collaboration with the molecular diagnostics firm Myriad Genetics’ for its tes...Read more
Innovus Pharmaceuticals, an emerging commercial-stage pharmaceutical company that delivers safe, innovative an...Read more
In a bid to further provide an impetus and boost Indian & Korean Medical Device Industry, The Associa...Read more
Europe’s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to supp...Read more
Asia’s CRO market on the rise
A Frost & Sullivan’s recent report forecasts a growth rate of 19.9 per cent for the contract research organizations (CROs) industry in Asia Pacific (APAC) region in the period between 2015 and 2020, while the CRO market in North America is expected to grow only at 10.4 per cent CAGR. With a fast-growing pharma market, large treatment-naïve population, highly skilled and internationally acclaimed investigators, high-quality data, and harmonized regulations, APAC has become a preferred outsourcing destination for clinical trials.